MS progression may occur with initial myelin-autoreactive CD4+ T helper cell activation in either the periphery or in the CNS, evident from studies of antigen-presenting B cell therapy in relapsing MS cases [180]. The gene discussed is CD4; the disease is myeloid sarcoma.